{"id":"NCT01853826","sponsor":"Boehringer Ingelheim","briefTitle":"An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)","officialTitle":"An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-17","primaryCompletion":"2024-03-06","completion":"2024-03-06","firstPosted":"2013-05-15","resultsPosted":"2025-04-11","lastUpdate":"2025-04-11"},"enrollment":481,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Non-Small-Cell Lung"],"interventions":[{"type":"DRUG","name":"Afatinib","otherNames":["GiotrifÂ®"]}],"arms":[{"label":"Afatinib treated-patients","type":"EXPERIMENTAL"}],"summary":"To evaluate the safety and tolerability of afatinib (Giotrif) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR mutation(s) and have never been treated with an EGFR-TKI","primaryOutcome":{"measure":"Number of Patients With Adverse Events According to Common Terminology Criteria for Adverse Events (CTCAE) Version 3.0","timeFrame":"From first drug administration to last drug administration plus 28 days of residual effect period. Up to 3866 days.","effectByArm":[{"arm":"Afatinib Treated-patients","deltaMin":478,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":118,"countries":["Australia","Austria","Czechia","Greece","Hungary","Israel","Italy","Poland","Portugal","Russia","Spain"]},"refs":{"pmids":[],"seeAlso":["https://www.mystudywindow.com"]},"adverseEventsSummary":{"seriousAny":{"events":210,"n":479},"commonTop":["Diarrhoea","Rash","Paronychia","Mucosal inflammation","Asthenia"]}}